Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey

To better understand the hepatocellular carcinoma (HCC) patient journey, we conducted a patient survey across 13 countries.The survey included closed- and open-ended questions developed using an iterative process to gather information on demographics, diagnosis and treatment. Patients self-selected or were directed to the online survey by their doctor.A total of 256 patients completed the survey. More than two-thirds (68%) felt they did not...